Catalyst Wire Dossier Catalyst Wire Dossier

Luminespib (AUY922)

luminespib · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Luminespib (AUY922), covering 2012-09-06 to 2012-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)

See pricing